Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morinidazole with Levofloxacin in PID
NCT03391440Phase 4Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of morinidazole in pelvic inflammatory disease (PID), sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
morinidazole
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT03391440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391440.